Products Categories
CAS No.: | 10176-39-3 |
---|---|
Name: | gitoformate |
Molecular Structure: | |
Formula: | C46H64 O19 |
Molecular Weight: | 921.10 |
Synonyms: | Gitoxin,pentaformate (7CI);AC 2770;Formiloxin;Formiloxine;Gitoformate;Pentaformylgitoxin; |
EINECS: | 233-450-3 |
Density: | 1.35g/cm3 |
Boiling Point: | 921.6°Cat760mmHg |
Flash Point: | 263.6°C |
Safety: | A poison by ingestion, subcutaneous, and intravenous routes. When heated to decomposition it emits acrid smoke and irritating vapors. |
PSA: | 233.41000 |
LogP: | 6.30110 |
IUPAC Name: [3-[5-[5-(4,5-Diformyloxy-6-methyloxan-2-yl)oxy-4-formyloxy-6-methyloxan-2-yl]oxy-4-formyloxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] formate
Synonyms of Pentaformylgitoxin (CAS NO.10176-39-3) : Formiloxin ; Formiloxine ; Gitoformate ; (3beta,5beta,16beta)-3-((O-2,6-Dideoxy-3,4-di-O-formyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-3-O-formyl-beta-D-ribo-hexanopyranosyl-(1-4)-2,6-dide oxy-3-O-formyl-beta-D-ribo-hexanopyranosyl)oxy)-16-(formyloxy)-14-hydroxycard-20(22)-enolide ; Card-20(22)-enolide, 3-((O-2,6-dideoxy-3,4-di-O-formyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-3-O-formyl-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-3-O-formyl-beta-D-ribo-hexopyranosyl)oxy)-16-(formyloxy)-14-hydroxy-, (3-beta,5-beta,16-beta)- ; Gitoformate ; Gitoxin 3',3'',3''',4''',16-pentaformate
CAS NO: 10176-39-3
Molecular Formula of Pentaformylgitoxin (CAS NO.10176-39-3) :C46H64O19
Molecular Weight of Pentaformylgitoxin (CAS NO.10176-39-3) :920.989
Molecular Structure of Pentaformylgitoxin (CAS NO.10176-39-3) :
Index of Refraction:1.567
Surface Tension: 58.9 dyne/cm
Density: 1.35 g/cm3
Flash Point: 263.6 °C
Enthalpy of Vaporization: 152.12 kJ/mol
Boiling Point: 921.6 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | intravenous | 1780ug/kg (1.78mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 164, Pg. 47, 1966. | |
dog | LDLo | intravenous | 1840ug/kg (1.84mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 164, Pg. 47, 1966. | |
guinea pig | LD50 | oral | 1250ug/kg (1.25mg/kg) | Medicamentos de Actualidad. Vol. 15, Pg. 407, 1979. | |
guinea pig | LDLo | intravenous | 734ug/kg (0.734mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 153, Pg. 436, 1965. |
mouse | LD50 | oral | 2390ug/kg (2.39mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: OTHER CHANGES | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 153, Pg. 436, 1965. |
mouse | LD50 | subcutaneous | 2270ug/kg (2.27mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 153, Pg. 436, 1965. |
rat | LD50 | oral | 39010ug/kg (39.01mg/kg) | Medicamentos de Actualidad. Vol. 15, Pg. 407, 1979. | |
rat | LD50 | subcutaneous | 21290ug/kg (21.29mg/kg) | Medicamentos de Actualidad. Vol. 15, Pg. 407, 1979. |
A poison by ingestion, subcutaneous, and intravenous routes. When Pentaformylgitoxin (CAS NO.10176-39-3) is heated to decomposition, it emits acrid smoke and irritating vapors.
RIDADR 2811
HazardClass 6.1(b)
PackingGroup III